Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Harte Hanks (HHS) Shares Outstanding (2016 - 2025)

Harte Hanks has reported Shares Outstanding over the past 16 years, most recently at $12.2 million for Q4 2025.

  • Quarterly Shares Outstanding rose 66.11% to $12.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $12.2 million through Dec 2025, up 66.11% year-over-year, with the annual reading at $12.2 million for FY2025, 66.11% up from the prior year.
  • Shares Outstanding was $7.4 million for Q4 2025 at Harte Hanks, roughly flat from $7.4 million in the prior quarter.
  • Over five years, Shares Outstanding peaked at $12.2 million in Q1 2023 and troughed at $6.7 million in Q1 2021.
  • The 5-year median for Shares Outstanding is $7.3 million (2024), against an average of $8.2 million.
  • Year-over-year, Shares Outstanding plummeted 44.04% in 2021 and then skyrocketed 69.32% in 2023.
  • A 5-year view of Shares Outstanding shows it stood at $7.0 million in 2021, then grew by 6.11% to $7.4 million in 2022, then fell by 2.4% to $7.2 million in 2023, then increased by 1.84% to $7.4 million in 2024, then surged by 66.11% to $12.2 million in 2025.
  • Per Business Quant, the three most recent readings for HHS's Shares Outstanding are $12.2 million (Q4 2025), $7.4 million (Q3 2025), and $7.4 million (Q2 2025).